'You've got to get away from whatever you do to make a living or other parts of life that stress you out,' said Jimmy Buffett once said

Volodymyr Zelensky will travel in person to Japan for the Group of Seven (G7) summit, according to officials familiar with the planning, a stark display of confidence and Western solidarity as Ukraine's wartime leader tries to keep crucial support from allied nations flowing.

BAGHDAD A fire that swept through a crowded wedding hall in a northern Iraqi town killing more than

An announcement is likely soon on the UK becoming a fully-fledged member of the multi-billion euro programme.

Tunisia is hosting the leaders of Italy, the Netherlands and the European Union for talks aimed at smoothing the way for an international bailout

Cricket's more than 100-year Olympic exile moved closer to ending after the sport was approved for inclusion at the 2028 Los Angeles Games by the...

Steve Sleight, a mountain guide living in Morocco, is helping those caught up in the disaster.

Brad Pitt, Johnny Depp, John Cusack, Matthew McConaughey, Sean Penn, and Leonardo DiCaprio have all wanted to play Billy Milligan at different points

Five conservative cardinals are challenging Pope Francis to affirm Catholic teaching on homosexuality and female ordination

Tristen Newton scored 22 points Saturday to lead No. 6 UConn to a 107-67 rout of Stonehill College

A treatment for acute migraines has been approved for NHS use for the first time, with experts saying the move could be a “step-change” for thousands of people who suffer from the condition. The National Institute for Health and Care Excellence (Nice) said its final draft guidance on Rimegepant “addresses the high unmet need for treatment options for acute migraine”. Rimegepant, also known as Vydura and made by Pfizer, will be available to adults who have tried at least two triptans – medication usually given to tackle headaches or migraines – but found they did not work well enough. It can also be administered to those who are not able to take triptans or have an intolerance, or patients who have tried nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol. Helen Knight, director of medicines evaluation at Nice, said: “Migraine is a condition described in comments to Nice from carers and people with migraine as an invisible disability that affects all aspects of life including work, education, finances, mental health, social activities and family. “Today’s final draft guidance addresses the high unmet need for treatment options for acute migraine, once again demonstrating our ability to ensure clinically and cost-effective medicines are available to those who need them as quickly as possible.” Rimegepant is taken as a wafer, which dissolves under the tongue and works by stopping the release of a protein around the brain called calcitonin gene-related peptide. In July, the medicine was recommended as an option for preventing episodic migraines in adults who have at least four and fewer than 15 attacks per month if “at least” three other treatments have not worked. This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment Helen Knight, Nice Under the latest guidance, it will also be used to relieve symptoms of a migraine, which can include pain, nausea and sensitivity to light, but also painless symptoms such as temporary visual disturbances known as “aura”, which Nice said “is not well managed with existing treatments”. The recommendation is expected to benefit about 13,000 people. Ms Knight added: “This is the first and only Nice-recommended medicine that can help alleviate the misery of acute migraines, and may be considered a step-change in treatment.” Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health Robert Music, The Migraine Trust Robert Music, chief executive of The Migraine Trust, said the Nice guidance “provides people with migraine valuable options to help reduce the pain and length of a migraine attack”. “It brings new hope,” he added. “It will especially benefit those who have not found a treatment that works, those who get debilitating side effects – including medicine overuse headache – from them, and those with cardiovascular disease who cannot take existing treatments. “Migraine is an incredibly misunderstood condition that can have a significant impact on all areas of life, including ability to work, maintain relationships and mental health.” Read More NHS winter resilience fund announced by Government NHS reliance on paper notes ‘stopping trusts from realising full potential’ Recession fears as UK economy shrinks by more than expected in shock decline Charity boss speaks out over ‘traumatic’ encounter with royal aide Ukraine war’s heaviest fight rages in east - follow live

The cuisine, wildly popular in Indian streets and restaurants, is now finding a place on food menus in the US.